Enzymes for N-Glycan branching and their genetic and nongenetic regulation in cancer

Biomolecules

Volumn 6, Issue 2, 2016, Pages

  Kizuka, Yasuhiko ^a   Taniguchi, Naoyuki ^a  

^a RIKEN   (Japan)

Author keywords

Cancer; Fucose; GlcNAc; Glycosylation; Glycosyltransferase; N Glycan

Indexed keywords

1,4 ALPHA GLUCAN BRANCHING ENZYME; ALPHA FETOPROTEIN; ENZYME; FUCOSE; FUT8 ENZYME; GLYCAN; GLYCOSYLTRANSFERASE; GNT III ENZYME; GNT IVA C ENZYME; GNT V ENZYME; GNT VB (IX) ENZYME; MANNOSE; UNCLASSIFIED DRUG; ENZYME INHIBITOR; FUCOSYLTRANSFERASE; N ACETYLGLUCOSAMINYLTRANSFERASE; POLYSACCHARIDE;

CANCER THERAPY; CELLULAR DISTRIBUTION; DNA METHYLATION; DOWN REGULATION; DRUG TARGETING; ENZYME ACTIVITY; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; FUCOSYLATION; GENETIC REGULATION; GLUCOSE TOLERANCE; HUMAN; MASS SPECTROMETRY; MOLECULAR DYNAMICS; NEOPLASM; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION; ANTAGONISTS AND INHIBITORS; GENETIC EPIGENESIS; GENETICS; GLYCOSYLATION; METABOLISM; NEOPLASMS; PATHOLOGY;

ENZYME INHIBITORS; EPIGENESIS, GENETIC; FUCOSYLTRANSFERASES; GLYCOSYLATION; HUMANS; N-ACETYLGLUCOSAMINYLTRANSFERASES; NEOPLASMS; POLYSACCHARIDES;

EID: 85012073773     PISSN: None     EISSN: 2218273X     Source Type: Journal    
DOI: 10.3390/biom6020025     Document Type: Review

References (162)

1. Moremen, K.W, Tiemeyer, M, Nairn, A.V. Vertebrate protein glycosylation: Diversity, synthesis and function. Nat. Rev. Mol. Cell Biol. 2012, 13, 448-462. [CrossRef]
2. Pinho, S.S, Reis, C.A. Glycosylation in cancer: Mechanisms and clinical implications. Nat. Rev. Cancer 2015, 15, 540-555. [CrossRef] [PubMed]
3. Taniguchi, N, Kizuka, Y. Glycans and cancer: Role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics. Adv. Cancer Res. 2015, 126, 11-51.
4. Hakomori, S. Glycosylation defining cancer malignancy: New wine in an old bottle. Proc. Natl. Acad. Sci. USA 2002, 99, 10231-10233. [CrossRef]
5. Stanley, P, Schachter, H, Taniguchi, N. N-glycans. In Essentials of glycobiology, 2nd ed, Varki, A., Cummings, R.D., Esko, J.D., Freeze, H.H., Stanley, P., Bertozzi, C.R., Hart, G.W., Etzler, M.E., Eds, Cold Spring Harbor: New York, NY, USA, 2009.
6. Taniguchi, N, Korekane, H. Branched N-glycans and their implications for cell adhesion, signaling and clinical applications for cancer biomarkers and in therapeutics. BMB Rep. 2011, 44, 772-781. [CrossRef]
7. Ikeda, Y, Ihara, H, Tsukamoto, H, Gu, J, Taniguchi, N. Mannosyl (beta-1,4-)-glycoprotein beta-1,4-Nacetylglucosaminyltransferase (mgat3); β1,4-N-acetylglucosaminyltransferase III (gnt-III, glcnact-III). In Handbook of Glycosyltransferases and Related Genes; Taniguchi, N., Honke, K., Fukuda, M., Narimatsu, H., Yamaguchi, Y., Angata, T., Eds, Springer Japan: Tokyo, Japan, 2014; pp. 209-222.
8. Zhao, Y, Sato, Y, Isaji, T, Fukuda, T, Matsumoto, A, Miyoshi, E, Gu, J, Taniguchi, N. Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J. 2008, 275, 1939-1948. [CrossRef] [PubMed]
9. Schachter, H. Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. Biochem. Cell Biol. 1986, 64, 163-181. [CrossRef] [PubMed]
10. Gu, J, Nishikawa, A, Tsuruoka, N, Ohno, M, Yamaguchi, N, Kangawa, K, Taniguchi, N. Purification and characterization of udp-N-acetylglucosamine: Alpha-6-d-mannoside beta 1-6n-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase v) from a human lung cancer cell line. J. Biochem. 1993, 113, 614-619. [PubMed]
11. Re, S, Miyashita, N, Yamaguchi, Y, Sugita, Y. Structural diversity and changes in conformational equilibria of biantennary complex-type N-glycans in water revealed by replica-exchange molecular dynamics simulation. Biophys. J. 2011, 101, L44-L46. [CrossRef] [PubMed]
12. Nagae, M, Kanagawa, M, Morita-Matsumoto, K, Hanashima, S, Kizuka, Y, Taniguchi, N, Yamaguchi, Y. Atomic visualization of a flipped-back conformation of bisected glycans bound to specific lectins. Sci. Rep. 2016, 6, 22973. [CrossRef] [PubMed]
13. Fujii, S, Nishiura, T, Nishikawa, A, Miura, R, Taniguchi, N. Structural heterogeneity of sugar chains in immunoglobulin G. Conformation of immunoglobulin g molecule and substrate specificities of glycosyltransferases. J. Biol. Chem. 1990, 265, 6009-6018. [PubMed]
14. Taniguchi, N, Yoshimura, M, Miyoshi, E, Ihara, Y, Nishikawa, A, Fujii, S. Remodeling of cell surface glycoproteins by N-acetylglucosaminyltransferase iii gene transfection: Modulation of metastatic potentials and down regulation of hepatitis b virus replication. Glycobiology 1996, 6, 691-694. [CrossRef] [PubMed]
15. Narasimhan, S.Control of glycoprotein synthesis. Udp-glcnac:Glycopeptide beta 4-N-acetylglucosaminyltransferase iii, an enzyme in hen oviduct which adds glcnac in beta 1-4 linkage to the beta-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides. J. Biol. Chem. 1982, 257, 10235-10242. [PubMed]
16. Gleeson, P.A, Schachter, H. Control of glycoprotein synthesis. J. Biol. Chem. 1983, 258, 6162-6173. [PubMed]
17. Nishikawa, A, Ihara, Y, Hatakeyama, M, Kangawa, K, Taniguchi, N. Purification, cdna cloning, and expression of udp-N-acetylglucosamine: Beta-d-mannoside beta-1,4n-acetylglucosaminyltransferase iii from rat kidney. J. Biol. Chem. 1992, 267, 18199-18204. [PubMed]
18. Miyoshi, E, Nishikawa, A, Ihara, Y, Gu, J, Sugiyama, T, Hayashi, N, Fusamoto, H, Kamada, T, Taniguchi, N. N-acetylglucosaminyltransferase III and V messenger rna levels in lec rats during hepatocarcinogenesis. Cancer Res. 1993, 53, 3899-3902. [PubMed]
19. Abbott, K.L, Nairn, A.V, Hall, E.M, Horton, M.B, McDonald, J.F, Moremen, K.W, Dinulescu, D.M, Pierce, M. Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer. Proteomics 2008, 8, 3210-3220. [CrossRef] [PubMed]
20. Yoshimura, M, Nishikawa, A, Ihara, Y, Nishiura, T, Nakao, H, Kanayama, Y, Matuzawa, Y, Taniguchi, N. High expression of udp-N-acetylglucosamine: Beta-d mannoside beta-1,4-N-acetylglucosaminyltransferase iii (gnt-iii) in chronic myelogenous leukemia in blast crisis. Int. J. Cancer 1995, 60, 443-449. [CrossRef] [PubMed]
21. Yoshimura, M, Nishikawa, A, Ihara, Y, Taniguchi, S, Taniguchi, N. Suppression of lung metastasis of b16 mouse melanoma by N-acetylglucosaminyltransferase iii gene transfection. Proc. Natl. Acad. Sci. USA 1995, 92, 8754-8758. [CrossRef] [PubMed]
22. Song, Y, Aglipay, J.A, Bernstein, J.D, Goswami, S, Stanley, P. The bisecting glcnac on N-glycans inhibits growth factor signaling and retards mammary tumor progression. Cancer Res. 2010, 70, 3361-3371. [CrossRef] [PubMed]
23. Yoshimura, M, Ihara, Y, Matsuzawa, Y, Taniguchi, N. Aberrant glycosylation of e-cadherin enhances cell-cell binding to suppress metastasis. J. Biol. Chem. 1996, 271, 13811-13815. [PubMed]
24. Pinho, S.S, Reis, C.A, Paredes, J, Magalhaes, A.M, Ferreira, A.C, Figueiredo, J, Xiaogang, W, Carneiro, F, Gartner, F, Seruca, R. The role of N-acetylglucosaminyltransferase iii and v in the post-transcriptional modifications of e-cadherin. Hum. Mol. Genet. 2009, 18, 2599-2608. [CrossRef] [PubMed]
25. Iijima, J, Zhao, Y, Isaji, T, Kameyama, A, Nakaya, S, Wang, X, Ihara, H, Cheng, X, Nakagawa, T, Miyoshi, E, et al. Cell-cell interaction-dependent regulation of N-acetylglucosaminyltransferase iii and the bisected N-glycans in ge11 epithelial cells. Involvement of e-cadherin-mediated cell adhesion. J. Biol. Chem. 2006, 281, 13038-13046. [CrossRef] [PubMed]
26. Isaji, T, Gu, J, Nishiuchi, R, Zhao, Y, Takahashi, M, Miyoshi, E, Honke, K, Sekiguchi, K, Taniguchi, N. Introduction of bisecting glcnac into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration. J. Biol. Chem. 2004, 279, 19747-19754. [CrossRef] [PubMed]
27. Kariya, Y, Kato, R, Itoh, S, Fukuda, T, Shibukawa, Y, Sanzen, N, Sekiguchi, K, Wada, Y, Kawasaki, N, Gu, J. N-glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting glcnac. J. Biol. Chem. 2008, 283, 33036-33045. [CrossRef] [PubMed]
28. Kitada, T, Miyoshi, E, Noda, K, Higashiyama, S, Ihara, H, Matsuura, N, Hayashi, N, Kawata, S, Matsuzawa, Y, Taniguchi, N. The addition of bisecting N-acetylglucosamine residues to e-cadherin down-regulates the tyrosine phosphorylation of beta-catenin. J. Biol. Chem. 2001, 276, 475-480. [CrossRef] [PubMed]
29. Pinho, S.S, Seruca, R, Gartner, F, Yamaguchi, Y, Gu, J, Taniguchi, N, Reis, C.A. Modulation of e-cadherin function and dysfunction by N-glycosylation. Cell Mol. Life Sci. 2011, 68, 1011-1020. [CrossRef] [PubMed]
30. Xu, Q, Isaji, T, Lu, Y, Gu, W, Kondo, M, Fukuda, T, Du, Y, Gu, J. Roles of N-acetylglucosaminyltransferase iii in epithelial-to-mesenchymal transition induced by transforming growth factor beta1 (TGF-beta1) in epithelial cell lines. J. Biol. Chem. 2012, 287, 16563-16574. [CrossRef] [PubMed]
31. Pinho, S.S, Oliveira, P, Cabral, J, Carvalho, S, Huntsman, D, Gartner, F, Seruca, R, Reis, C.A, Oliveira, C. Loss and recovery of mgat3 and GnT-III mediated e-cadherin N-glycosylation is a mechanism involved in epithelial-mesenchymal-epithelial transitions. PLoS ONE 2012, 7, e33191. [CrossRef] [PubMed]
32. Lu, J, Isaji, T, Im, S, Fukuda, T, Kameyama, A, Gu, J. Expression of N-acetylglucosaminyltransferase iii suppresses alpha2,3 sialylation and its distinctive functions in cell migration are attributed to alpha2,6 sialylation levels. J. Biol. Chem. 2016, 291, 5708-5720. [CrossRef] [PubMed]
33. Yang, X, Tang, J, Rogler, C.E, Stanley, P. Reduced hepatocyte proliferation is the basis of retarded liver tumor progression and liver regeneration in mice lacking N-acetylglucosaminyltransferase III. Cancer Res. 2003, 63, 7753-7759. [PubMed]
34. Yoshimura, M, Ihara, Y, Ohnishi, A, Ijuhin, N, Nishiura, T, Kanakura, Y, Matsuzawa, Y, Taniguchi, N. Bisecting N-acetylglucosamine on k562 cells suppresses natural killer cytotoxicity and promotes spleen colonization. Cancer Res. 1996, 56, 412-418. [PubMed]
35. Kizuka, Y, Kitazume, S, Fujinawa, R, Saito, T, Iwata, N, Saido, T.C, Nakano, M, Yamaguchi, Y, Hashimoto, Y, Staufenbiel, M, et al. An aberrant sugar modification of bace1 blocks its lysosomal targeting in Alzheimer's disease. EMBO Mol. Med. 2015, 7, 175-189. [CrossRef] [PubMed]
36. Kizuka, Y, Nakano, M, Kitazume, S, Saito, T, Saido, T.C, Taniguchi, N. Bisecting glcnac modification stabilizes bace1 protein under oxidative stress conditions. Biochem. J. 2015, 473, 21-30. [CrossRef] [PubMed]
37. Dennis, J.W, Taniguchi, N, Pierce, M. Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetylglucosaminyltransferase (mgat5). In Handbook of Glycosyltransferases and Related Genes; Taniguchi, N., Honke, K., Fukuda, M., Narimatsu, H., Yamaguchi, Y., Angata, T., Eds, Springer Japan: Tokyo, Japan, 2014; pp. 233-246.
38. Shoreibah, M, Perng, G.S, Adler, B, Weinstein, J, Basu, R, Cupples, R, Wen, D, Browne, J.K, Buckhaults, P, Fregien, N, et al. Isolation, characterization, and expression of a cdna encoding N-acetylglucosaminyltransferase V. J. Biol. Chem. 1993, 268, 15381-15385. [PubMed]
39. Shoreibah, M.G, Hindsgaul, O, Pierce, M. Purification and characterization of rat kidney udp-N-acetylglucosamine: Alpha-6-d-mannoside beta-1,6-N-acetylglucosaminyltransferase. J. Biol. Chem. 1992, 267, 2920-2927. [PubMed]
40. Dennis, J.W, Nabi, I.R, Demetriou, M. Metabolism, cell surface organization, and disease. Cell 2009, 139, 1229-1241. [CrossRef] [PubMed]
41. Boscher, C, Dennis, J.W, Nabi, I.R. Glycosylation, galectins and cellular signaling. Curr. Opin. Cell Biol. 2011, 23, 383-392. [CrossRef] [PubMed]
42. Ihara, S, Miyoshi, E, Ko, J.H, Murata, K, Nakahara, S, Honke, K, Dickson, R.B, Lin, C.Y, Taniguchi, N. Prometastatic effect of N-acetylglucosaminyltransferase v is due to modification and stabilization of active matriptase by adding beta 1-6 glcnac branching. J. Biol. Chem. 2002, 277, 16960-16967. [CrossRef] [PubMed]
43. Ihara, S, Miyoshi, E, Nakahara, S, Sakiyama, H, Ihara, H, Akinaga, A, Honke, K, Dickson, R.B, Lin, C.Y, Taniguchi, N. Addition of beta1-6 glcnac branching to the oligosaccharide attached to asn 772 in the serine protease domain of matriptase plays a pivotal role in its stability and resistance against trypsin. Glycobiology 2004, 14, 139-146. [CrossRef] [PubMed]
44. Carvalho, S, Catarino, T.A, Dias, A.M, Kato, M, Almeida, A, Hessling, B, Figueiredo, J, Gartner, F, Sanches, J.M, Ruppert, T, et al. Preventing e-cadherin aberrant N-glycosylation at asn-554 improves its critical function in gastric cancer. Oncogene 2016, 35, 1619-1631. [CrossRef]
45. Guo, H.B, Johnson, H, Randolph, M, Pierce, M. Regulation of homotypic cell-cell adhesion by branched N-glycosylation of N-cadherin extracellular ec2 and ec3 domains. J. Biol. Chem. 2009, 284, 34986-34997. [CrossRef] [PubMed]
46. Pinho, S.S, Figueiredo, J, Cabral, J, Carvalho, S, Dourado, J, Magalhaes, A, Gartner, F, Mendonfa, A.M, Isaji, T, Gu, J, et al. E-cadherin and adherens-junctions stability in gastric carcinoma: Functional implications of glycosyltransferases involving N-glycan branching biosynthesis, N-acetylglucosaminyltransferases iii and v. Biochim. Biophys. Acta 2013, 1830, 2690-2700. [CrossRef] [PubMed]
47. Saito, T, Miyoshi, E, Sasai, K, Nakano, N, Eguchi, H, Honke, K, Taniguchi, N. A secreted type of beta 1,6-N-acetylglucosaminyltransferase v (GnT-V) induces tumor angiogenesis without mediation of glycosylation: A novel function of gnt-v distinct from the original glycosyltransferase activity. J. Biol. Chem. 2002, 277, 17002-17008. [CrossRef] [PubMed]
48. Yanagi, M, Aoyagi, Y, Suda, T, Mita, Y, Asakura, H. N-acetylglucosaminyltransferase V as a possible aid for the evaluation of tumor invasiveness in patients with hepatocellular carcinoma. J. Gastroenterol. Hepatol. 2001, 16, 1282-1289. [CrossRef] [PubMed]
49. Ohtsubo, K, Marth, J.D. Glycosylation in cellular mechanisms of health and disease. Cell 2006, 126, 855-867. [CrossRef] [PubMed]
50. Kuhn, P.H, Voss, M, Haug-Kroper, M, Schroder, B, Schepers, U, Brase, S, Haass, C, Lichtenthaler, S.F, Fluhrer, R. Secretome analysis identifies novel signal peptide peptidase-like 3 (SPPL3) substrates and reveals a role of SPPL3 in multiple Golgi glycosylation pathways. Mol. Cell. Proteomics 2015, 14, 1584-1598. [CrossRef] [PubMed]
51. Voss, M, Kunzel, U, Higel, F, Kuhn, P.H, Colombo, A, Fukumori, A, Haug-Kroper, M, Klier, B, Grammer, G, Seidl, A, et al. Shedding of glycan-modifying enzymes by signal peptide peptidase-like 3 (SPPL3) regulates cellular N-glycosylation. EMBO J. 2014, 33, 2890-2905. [CrossRef] [PubMed]
52. Granovsky, M, Fata, J, Pawling, J, Muller, W.J, Khokha, R, Dennis, J.W. Suppression of tumor growth and metastasis in mgat5-deficient mice. Nat. Med. 2000, 6, 306-312. [PubMed]
53. Guo, H.B, Johnson, H, Randolph, M, Nagy, T, Blalock, R, Pierce, M. Specific posttranslational modification regulates early events in mammary carcinoma formation. Proc. Natl. Acad. Sci. USA 2010, 107, 21116-21121. [CrossRef] [PubMed]
54. Tian, H, Miyoshi, E, Kawaguchi, N, Shaker, M, Ito, Y, Taniguchi, N, Tsujimoto, M, Matsuura, N. The implication of N-acetylglucosaminyltransferase v expression in gastric cancer. Pathobiology 2008, 75, 288-294. [CrossRef] [PubMed]
55. Ishibashi, Y, Dosaka-Akita, H, Miyoshi, E, Shindoh, M, Miyamoto, M, Kinoshita, I, Miyazaki, H, Itoh, T, Kondo, S, Nishimura, M, et al. Expression of N-acetylglucosaminyltransferase V in the development of human esophageal cancers: Immunohistochemical data from carcinomas and nearby noncancerous lesions. Oncology 2005, 69, 301-310. [CrossRef] [PubMed]
56. Guo, H, Nagy, T, Pierce, M. Post-translational glycoprotein modifications regulate colon cancer stem cells and colon adenoma progression in apc(min/+) mice through altered wnt receptor signaling. J. Biol. Chem. 2014, 289, 31534-31549. [CrossRef] [PubMed]
57. Ito, Y, Miyoshi, E, Sakon, M, Takeda, T, Noda, K, Tsujimoto, M, Ito, S, Honda, H, Takemura, F, Wakasa, K, et al. Elevated expression of UDP-N-acetylglucosamine: Alphamannoside beta1,6 N-acetylglucosaminyltransferase is an early event in hepatocarcinogenesis. Int. J. Cancer 2001, 91, 631-637. [CrossRef]
58. Handerson, T, Camp, R, Harigopal, M, Rimm, D, Pawelek, J. Beta1,6-branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma. Clin. Cancer Res. 2005, 11, 2969-2973. [CrossRef] [PubMed]
59. Inamori, K, Endo, T, Ide, Y, Fujii, S, Gu, J, Honke, K, Taniguchi, N. Molecular cloning and characterization of human gnt-ix, a novel beta1,6-N-acetylglucosaminyltransferase that is specifically expressed in the brain. J. Biol. Chem. 2003, 278, 43102-43109. [CrossRef] [PubMed]
60. Kaneko, M, Alvarez-Manilla, G, Kamar, M, Lee, I, Lee, J.K, Troupe, K, Zhang, W, Osawa, M, Pierce, M. A novel beta(1,6)-N-acetylglucosaminyltransferase v (GnT-Vb)(1). FEBS Lett. 2003, 554, 515-519. [CrossRef]
61. Alvarez-Manilla, G, Troupe, K, Fleming, M, Martinez-Uribe, E, Pierce, M. Comparison of the substrate specificities and catalytic properties of the sister N-acetylglucosaminyltransferases, GnT-V and GnT-Vb (IX). Glycobiology 2010, 20, 166-174. [CrossRef] [PubMed]
62. Inamori, K, Endo, T, Gu, J, Matsuo, I, Ito, Y, Fujii, S, Iwasaki, H, Narimatsu, H, Miyoshi, E, Honke, K, et al. N-acetylglucosaminyltransferase ix acts on the glcnac beta 1,2-man alpha 1-ser/thr moiety, forming a 2,6-branched structure in brain O-mannosyl glycan. J. Biol. Chem. 2004, 279, 2337-2340. [CrossRef] [PubMed]
63. Inamori, K.-I, Pierce, M, Taniguchi, N. Mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetylglucosaminyltransferase, isozyme b (mgat5b). In Handbook of Glycosyltransferases and Related Genes; Taniguchi, N., Honke, K., Fukuda, M., Narimatsu, H., Yamaguchi, Y., Angata, T., Eds, Springer Japan: Tokyo, Japan, 2014; pp. 247-255.
64. Kizuka, Y, Kitazume, S, Okahara, K, Villagra, A, Sotomayor, E.M, Taniguchi, N. Epigenetic regulation of a brain-specific glycosyltransferase N-acetylglucosaminyltransferase-ix (GnT-IX) by specific chromatin modifiers. J. Biol. Chem. 2014, 289, 11253-11261. [CrossRef] [PubMed]
65. Kizuka, Y, Kitazume, S, Yoshida, M, Taniguchi, N. Brain-specific expression of N-acetylglucosaminyltransferase ix (GnT-IX) is regulated by epigenetic histone modifications. J. Biol. Chem. 2011, 286, 31875-31884. [CrossRef] [PubMed]
66. Kanekiyo, K, Inamori, K, Kitazume, S, Sato, K, Maeda, J, Higuchi, M, Kizuka, Y, Korekane, H, Matsuo, I, Honke, K, et al. Loss of branched o-mannosyl glycans in astrocytes accelerates remyelination. J. Neurosci. 2013, 33, 10037-10047. [CrossRef] [PubMed]
67. Abbott, K.L, Matthews, R.T, Pierce, M. Receptor tyrosine phosphatase beta (RPTPbeta) activity and signaling are attenuated by glycosylation and subsequent cell surface galectin-1 binding. J. Biol. Chem. 2008, 283, 33026-33035. [CrossRef] [PubMed]
68. Lommel, M, Winterhalter, P.R, Willer, T, Dahlhoff, M, Schneider, M.R, Bartels, M.F, Renner-Muller, I, Ruppert, T, Wolf, E, Strahl, S. Protein O-mannosylation is crucial for e-cadherin-mediated cell adhesion. Proc. Natl. Acad. Sci. USA 2013, 110, 21024-21029. [CrossRef] [PubMed]
69. Vester-Christensen, M.B, Halim, A, Joshi, H.J, Steentoft, C, Bennett, E.P, Levery, S.B, Vakhrushev, S.Y, Clausen, H. Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins. Proc. Natl. Acad. Sci. USA 2013, 110, 21018-21023. [CrossRef] [PubMed]
70. Endo, T. Glycobiology of alpha-dystroglycan and muscular dystrophy. J. Biochem. 2015, 157, 1-12. [CrossRef] [PubMed]
71. Kanagawa, M, Kobayashi, K, Tajiri, M, Manya, H, Kuga, A, Yamaguchi, Y, Akasaka-Manya, K, Furukawa, J, Mizuno, M, Kawakami, H, et al. Identification of a post-translational modification with ribitol-phosphate and its defect in muscular dystrophy. Cell Rep. 2016, 14, 2209-2223. [CrossRef] [PubMed]
72. Inamori, K, Gu, J, Ohira, M, Kawasaki, A, Nakamura, Y, Nakagawa, T, Kondo, A, Miyoshi, E, Nakagawara, A, Taniguchi, N. High expression of N-acetylglucosaminyltransferase V in favorable neuroblastomas: Involvement of its effect on apoptosis. FEBS Lett. 2006, 580, 627-632. [CrossRef]
73. Lange, T, Ullrich, S, Muller, I, Nentwich, M.F, Stubke, K, Feldhaus, S, Knies, C, Hellwinkel, O.J, Vessella, R.L, Abramjuk, C, et al. Human prostate cancer in a clinically relevant xenograft mouse model: Identification of beta(1,6)-branched oligosaccharides as a marker of tumor progression. Clin. Cancer Res. 2012, 18, 1364-1373. [CrossRef]
74. Vojta, A, Samarzija, I, Bockor, L, Zoldos, V. Glyco-genes change expression in cancer through aberrant methylation. Biochim. Biophys. Acta. 2016. [CrossRef]
75. Ohtsubo, K, Taniguchi, N. Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme a,b (mgat4a,b). In Handbook of Glycosyltransferases and Related Genes; Taniguchi, N., Honke, K., Fukuda, M., Narimatsu, H., Yamaguchi, Y., Angata, T., Eds, Springer Japan: Tokyo, Japan, 2014; pp. 223-232.
76. Oguri, S, Minowa, M.T, Ihara, Y, Taniguchi, N, Ikenaga, H, Takeuchi, M. Purification and characterization of udp-N-acetylglucosamine: Alpha1,3-d-mannoside beta1,4-N-acetylglucosaminyltransferase (N-acetylglucosaminyltransferase-iv) from bovine small intestine. J. Biol. Chem. 1997, 272, 22721-22727. [CrossRef] [PubMed]
77. Minowa, M.T, Oguri, S, Yoshida, A, Hara, T, Iwamatsu, A, Ikenaga, H, Takeuchi, M. Cdna cloning and expression of bovine udp-N-acetylglucosamine: Alpha1, 3-d-mannoside beta1,4-Nacetylglucosaminyltransferase iv. J. Biol. Chem. 1998, 273, 11556-11562. [CrossRef] [PubMed]
78. Takamatsu, S, Antonopoulos, A, Ohtsubo, K, Ditto, D, Chiba, Y, Le, D.T, Morris, H.R, Haslam, S.M, Dell, A, Marth, J.D, et al. Physiological and glycomic characterization of N-acetylglucosaminyltransferase- IVa and -IVb double deficient mice. Glycobiology 2010, 20, 485-497. [CrossRef] [PubMed]
79. Oguri, S, Yoshida, A, Minowa, M.T, Takeuchi, M. Kinetic properties and substrate specificities of two recombinant human N-acetylglucosaminyltransferase-IV isozymes. Glycoconj. J. 2006, 23, 473-480. [CrossRef] [PubMed]
80. Ohtsubo, K, Takamatsu, S, Minowa, M.T, Yoshida, A, Takeuchi, M, Marth, J.D. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 2005, 123, 1307-1321. [CrossRef] [PubMed]
81. Niimi, K, Yamamoto, E, Fujiwara, S, Shinjo, K, Kotani, T, Umezu, T, Kajiyama, H, Shibata, K, Ino, K, Kikkawa, F. High expression of N-acetylglucosaminyltransferase iva promotes invasion of choriocarcinoma. Br. J. Cancer. 2012, 107, 1969-1977. [CrossRef] [PubMed]
82. Ide, Y, Miyoshi, E, Nakagawa, T, Gu, J, Tanemura, M, Nishida, T, Ito, T, Yamamoto, H, Kozutsumi, Y, Taniguchi, N. Aberrant expression of N-acetylglucosaminyltransferase-iva and ivb (GnT-IVa and b) in pancreatic cancer. Biochem. Biophys. Res. Commun 2006, 341, 478-482. [CrossRef] [PubMed]
83. Fan, J, Wang, S, Yu, S, He, J, Zheng, W, Zhang, J. N-acetylglucosaminyltransferase IVa regulates metastatic potential of mouse hepatocarcinoma cells through glycosylation of cd147. Glycoconj. J. 2012, 29, 323-334. [CrossRef] [PubMed]
84. Ohtsubo, K, Chen, M.Z, Olefsky, J.M, Marth, J.D. Pathway to diabetes through attenuation of pancreatic beta cell glycosylation and glucose transport. Nat. Med. 2011, 17, 1067-1075. [CrossRef] [PubMed]
85. Ebrahim, A.H, Alalawi, Z, Mirandola, L, Rakhshanda, R, Dahlbeck, S, Nguyen, D, Jenkins, M, Grizzi, F, Cobos, E, Figueroa, J.A, et al. Galectins in cancer: Carcinogenesis, diagnosis and therapy. Ann. Transl. Med. 2014, 2, 88. [PubMed]
86. Ihara, H, Tsukamoto, H, Gu, J, Miyoshi, E, Taniguchi, N, Ikeda, Y. Fucosyltransferase 8. Gdp-fucose N-glycan core β6-fucosyltransferase (fut8). In Handbook of Glycosyltransferases and Related Genes; Taniguchi, N., Honke, K., Fukuda, M., Narimatsu, H., Yamaguchi, Y., Angata, T., Eds, Springer Japan: Tokyo, Japan, 2014; pp. 581-596.
87. Takahashi, M, Kuroki, Y, Ohtsubo, K, Taniguchi, N. Core fucose and bisecting glcnac, the direct modifiers of the N-glycan core: Their functions and target proteins. Carbohydr. Res. 2009, 344, 1387-1390. [CrossRef] [PubMed]
88. Brockhausen, I, Narasimhan, S, Schachter, H. The biosynthesis of highly branched N-glycans: Studies on the sequential pathway and functional role of N-acetylglucosaminyltransferases I, II, III, IV, V and VI. Biochimie 1988, 70, 1521-1533. [CrossRef]
89. Uozumi, N, Yanagidani, S, Miyoshi, E, Ihara, Y, Sakuma, T, Gao, C.X, Teshima, T, Fujii, S, Shiba, T, Taniguchi, N. Purification and cDNA cloning of porcine brain GDP-L-Fuc: N-acetyl-beta-d-glucosaminide alpha1->6fucosyltransferase. J. Biol. Chem. 1996, 271, 27810-27817. [CrossRef] [PubMed]
90. Yanagidani, S, Uozumi, N, Ihara, Y, Miyoshi, E, Yamaguchi, N, Taniguchi, N. Purification and cdna cloning of gdp-l-fuc: N-acetyl-beta-d-glucosaminide:Alpha1-6 fucosyltransferase (alpha1-6 fuct) from human gastric cancer MKN45 cells. J. Biochem. 1997, 121, 626-632. [CrossRef] [PubMed]
91. Miyoshi, E, Uozumi, N, Noda, K, Hayashi, N, Hori, M, Taniguchi, N. Expression of alpha1-6 fucosyltransferase in rat tissues and human cancer cell lines. Int. J. Cancer 1997, 72, 1117-1121. [CrossRef]
92. Noda, K, Miyoshi, E, Uozumi, N, Gao, C.X, Suzuki, K, Hayashi, N, Hori, M, Taniguchi, N. High expression of alpha-1-6 fucosyltransferase during rat hepatocarcinogenesis. Int. J. Cancer 1998, 75, 444-450. [CrossRef]
93. Honma, R, Kinoshita, I, Miyoshi, E, Tomaru, U, Matsuno, Y, Shimizu, Y, Takeuchi, S, Kobayashi, Y, Kaga, K, Taniguchi, N, et al. Expression of fucosyltransferase 8 is associated with an unfavorable clinical outcome in non-small cell lung cancers. Oncology 2015, 88, 298-308. [CrossRef] [PubMed]
94. Chen, C.Y, Jan, Y.H, Juan, Y.H, Yang, C.J, Huang, M.S, Yu, C.J, Yang, P.C, Hsiao, M, Hsu, T.L, Wong, C.H. Fucosyltransferase 8 as a functional regulator of nonsmall cell lung cancer. Proc. Natl. Acad. Sci. USA 2013, 110, 630-635. [CrossRef] [PubMed]
95. Wang, X, Inoue, S, Gu, J, Miyoshi, E, Noda, K, Li, W, Mizuno-Horikawa, Y, Nakano, M, Asahi, M, Takahashi, M, et al. Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fucose-deficient mice. Proc. Natl. Acad. Sci. USA 2005, 102, 15791-15796. [CrossRef] [PubMed]
96. Gao, C, Maeno, T, Ota, F, Ueno, M, Korekane, H, Takamatsu, S, Shirato, K, Matsumoto, A, Kobayashi, S, Yoshida, K, et al. Sensitivity of heterozygous alpha1,6-fucosyltransferase knock-out mice to cigarette smoke-induced emphysema: Implication of aberrant transforming growth factor-beta signaling and matrix metalloproteinase gene expression. J. Biol. Chem. 2012, 287, 16699-16708. [CrossRef] [PubMed]
97. Fukuda, T, Hashimoto, H, Okayasu, N, Kameyama, A, Onogi, H, Nakagawasai, O, Nakazawa, T, Kurosawa, T, Hao, Y, Isaji, T, et al. Alpha1,6-fucosyltransferase-deficient mice exhibit multiple behavioral abnormalities associated with a schizophrenia-like phenotype: Importance of the balance between the dopamine and serotonin systems. J. Biol. Chem. 2011, 286, 18434-18443. [CrossRef] [PubMed]
98. Gu, W, Fukuda, T, Isaji, T, Hang, Q, Lee, H.H, Sakai, S, Morise, J, Mitoma, J, Higashi, H, Taniguchi, N, et al. Loss of alpha1,6-fucosyltransferase decreases hippocampal long term potentiation: Implications for core fucosylation in the regulation of ampa receptor heteromerization and cellular signaling. J. Biol. Chem. 2015, 290, 17566-17575. [CrossRef] [PubMed]
99. Li, W, Yu, R, Ma, B, Yang, Y, Jiao, X, Liu, Y, Cao, H, Dong, W, Liu, L, Ma, K, et al. Core fucosylation of IGG b cell receptor is required for antigen recognition and antibody production. J. Immunol. 2015, 194, 2596-2606. [CrossRef] [PubMed]
100. Fujii, H, Shinzaki, S, Iijima, H, Wakamatsu, K, Iwamoto, C, Sobajima, T, Kuwahara, R, Hiyama, S, Hayashi, Y, Takamatsu, S, et al. Core fucosylation on T cells, required for activation of T-cell receptor signaling and induction of colitis in mice, is increased in patients with inflammatory bowel disease. Gastroenterology 2016, 150. [CrossRef] [PubMed]
101. Wang, X, Gu, J, Ihara, H, Miyoshi, E, Honke, K, Taniguchi, N. Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling. J. Biol. Chem. 2006, 281, 2572-2577. [CrossRef] [PubMed]
102. Liu, Y.C, Yen, H.Y, Chen, C.Y, Chen, C.H, Cheng, P.F, Juan, Y.H, Chen, C.H, Khoo, K.H, Yu, C.J, Yang, P.C, et al. Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells. Proc. Natl. Acad. Sci. USA 2011, 108, 11332-11337. [CrossRef] [PubMed]
103. Wang, Y, Fukuda, T, Isaji, T, Lu, J, Gu, W, Lee, H.H, Ohkubo, Y, Kamada, Y, Taniguchi, N, Miyoshi, E, et al. Loss of alpha1,6-fucosyltransferase suppressed liver regeneration: Implication of core fucose in the regulation of growth factor receptor-mediated cellular signaling. Sci. Rep. 2015, 5, 8264. [CrossRef] [PubMed]
104. Wang, Y, Fukuda, T, Isaji, T, Lu, J, Im, S, Hang, Q, Gu, W, Hou, S, Ohtsubo, K, Gu, J. Loss of alpha1,6-fucosyltransferase inhibits chemical-induced hepatocellular carcinoma and tumorigenesis by down-regulating several cell signaling pathways. FASEB J. 2015, 29, 3217-3227. [CrossRef] [PubMed]
105. Potapenko, I.O, Haakensen, V.D, Luders, T, Helland, A, Bukholm, I, Sorlie, T, Kristensen, V.N, Lingjaerde, O.C, Borresen-Dale, A.L. Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression. Mol. Oncol. 2010, 4, 98-118. [CrossRef] [PubMed]
106. Wang, X, Chen, J, Li, Q.K, Peskoe, S.B, Zhang, B, Choi, C, Platz, E.A, Zhang, H. Overexpression of alpha (1,6) fucosyltransferase associated with aggressive prostate cancer. Glycobiology 2014, 24, 935-944. [CrossRef] [PubMed]
107. Saldova, R, Fan, Y, Fitzpatrick, J.M, Watson, R.W, Rudd, P.M. Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. Glycobiology 2011, 21, 195-205. [CrossRef] [PubMed]
108. Taketa, K, Endo, Y, Sekiya, C, Tanikawa, K, Koji, T, Taga, H, Satomura, S, Matsuura, S, Kawai, T, Hirai, H. A collaborative study for the evaluation of lectin-reactive alpha-fetoproteins in early detection of hepatocellular carcinoma. Cancer Res. 1993, 53, 5419-5423. [PubMed]
109. Toyoda, H, Kumada, T, Tada, T. Highly sensitive lens culinaris agglutinin-reactive alpha-fetoprotein: A new tool for the management of hepatocellular carcinoma. Oncology 2011, 81 Suppl 1, 61-65. [CrossRef] [PubMed]
110. Abelev, G.I. Alpha-fetoprotein in ontogenesis and its association with malignant tumors. Adv. Cancer Res. 1971, 14, 295-358. [PubMed]
111. Nakagawa, T, Miyoshi, E, Yakushijin, T, Hiramatsu, N, Igura, T, Hayashi, N, Taniguchi, N, Kondo, A. Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients. J. Proteome Res. 2008, 7, 2222-2233. [CrossRef] [PubMed]
112. Miyoshi, E, Moriwaki, K, Terao, N, Tan, C.C, Terao, M, Nakagawa, T, Matsumoto, H, Shinzaki, S, Kamada, Y. Fucosylation is a promising target for cancer diagnosis and therapy. Biomolecules 2012, 2, 34-45. [CrossRef] [PubMed]
113. Okuyama, N, Ide, Y, Nakano, M, Nakagawa, T, Yamanaka, K, Moriwaki, K, Murata, K, Ohigashi, H, Yokoyama, S, Eguchi, H, et al. Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer 2006, 118, 2803-2808. [CrossRef] [PubMed]
114. Takahashi, S, Sugiyama, T, Shimomura, M, Kamada, Y, Fujita, K, Nonomura, N, Miyoshi, E, Nakano, M. Site-specific and linkage analyses of fucosylated N-glycans on haptoglobin in sera of patients with various types of cancer: Possible implication for the differential diagnosis of cancer. Glycoconj. J. 2016, 33. [CrossRef] [PubMed]
115. Shuptrine, C.W, Surana, R, Weiner, L.M. Monoclonal antibodies for the treatment of cancer. Semin. Cancer Biol. 2012, 22, 3-13. [CrossRef] [PubMed]
116. Shields, R.L, Lai, J, Keck, R, O'Connell, L.Y, Hong, K, Meng, Y.G, Weikert, S.H, Presta, L.G. Lack of fucose on human IGG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J. Biol. Chem. 2002, 277, 26733-26740. [CrossRef] [PubMed]
117. Shinkawa, T, Nakamura, K, Yamane, N, Shoji-Hosaka, E, Kanda, Y, Sakurada, M, Uchida, K, Anazawa, H, Satoh, M, Yamasaki, M, et al. The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IGG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity. J. Biol. Chem. 2003, 278, 3466-3473. [CrossRef] [PubMed]
118. Reusch, D, Tejada, M.L. Fc glycans of therapeutic antibodies as critical quality attributes. Glycobiology 2015, 25, 1325-1334. [CrossRef] [PubMed]
119. Costa, A.R, Rodrigues, M.E, Henriques, M, Oliveira, R, Azeredo, J. Glycosylation: Impact, control and improvement during therapeutic protein production. Crit. Rev. Biotechnol. 2014, 34, 281-299. [CrossRef] [PubMed]
120. Buckhaults, P, Chen, L, Fregien, N, Pierce, M. Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene. J. Biol. Chem. 1997, 272, 19575-19581. [CrossRef] [PubMed]
121. Chen, L, Zhang, W, Fregien, N, Pierce, M. The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products. Oncogene 1998, 17, 2087-2093. [CrossRef] [PubMed]
122. Kang, R, Saito, H, Ihara, Y, Miyoshi, E, Koyama, N, Sheng, Y, Taniguchi, N. Transcriptional regulation of the N-acetylglucosaminyltransferase V gene in human bile duct carcinoma cells (HuCC-T1) is mediated by ets-1. J. Biol. Chem. 1996, 271, 26706-26712. [PubMed]
123. Ko, J.H, Miyoshi, E, Noda, K, Ekuni, A, Kang, R, Ikeda, Y, Taniguchi, N. Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines. J. Biol. Chem. 1999, 274, 22941-22948. [CrossRef] [PubMed]
124. Lauc, G, Essafi, A, Huffman, J.E, Hayward, C, Knezevic, A, Kattla, J.J, Polasek, O, Gornik, O, Vitart, V, Abrahams, J.L, et al. Genomics meets glycomics-the first gwas study of human N-glycome identifies HNF1alpha as a master regulator of plasma protein fucosylation. PLoS Genet. 2010, 6, e1001256. [CrossRef] [PubMed]
125. Akama, R, Sato, Y, Kariya, Y, Isaji, T, Fukuda, T, Lu, L, Taniguchi, N, Ozawa, M, Gu, J. N-acetylglucosaminyltransferase III expression is regulated by cell-cell adhesion via the e-cadherincatenin- actin complex. Proteomics 2008, 8, 3221-3228. [CrossRef] [PubMed]
126. Xu, Q, Akama, R, Isaji, T, Lu, Y, Hashimoto, H, Kariya, Y, Fukuda, T, Du, Y, Gu, J. Wnt/beta-catenin signaling down-regulates N-acetylglucosaminyltransferase III expression: The implications of two mutually exclusive pathways for regulation. J. Biol. Chem. 2011, 286, 4310-4318. [CrossRef] [PubMed]
127. Kurimoto, A, Kitazume, S, Kizuka, Y, Nakajima, K, Oka, R, Fujinawa, R, Korekane, H, Yamaguchi, Y, Wada, Y, Taniguchi, N. The absence of core fucose up-regulates GnT-III and WNT target genes: A possible mechanism for an adaptive response in terms of glycan function. J. Biol. Chem. 2014, 289, 11704-11714. [CrossRef] [PubMed]
128. Bonasio, R, Tu, S, Reinberg, D. Molecular signals of epigenetic states. Science 2010, 330, 612-616. [CrossRef] [PubMed]
129. Plass, C, Pfister, S.M, Lindroth, A.M, Bogatyrova, O, Claus, R, Lichter, P. Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat. Rev. Genet. 2013, 14, 765-780. [CrossRef] [PubMed]
130. Bergman, Y, Cedar, H. DNA methylation dynamics in health and disease. Nat. Struct. Mol. Biol. 2013, 20, 274-281. [CrossRef] [PubMed]
131. Jeschke, J, Collignon, E, Fuks, F. Portraits of TET-mediated DNA hydroxymethylation in cancer. Curr. Opin. Genet. Dev. 2016, 36, 16-26. [CrossRef] [PubMed]
132. Anugraham, M, Jacob, F, Nixdorf, S, Everest-Dass, A.V, Heinzelmann-Schwarz, V, Packer, N.H. Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: Glycan structures reflect gene expression and DNA methylation status. Mol. Cell. Proteomics 2014, 13, 2213-2232. [CrossRef] [PubMed]
133. Saldova, R, Dempsey, E, Perez-Garay, M, Marino, K, Watson, J.A, Blanco-Fernandez, A, Struwe, W.B, Harvey, D.J, Madden, S.F, Peracaula, R, et al. 5-aza-21-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer. Epigenetics 2011, 6, 1362-1372. [CrossRef] [PubMed]
134. Bannister, A.J, Kouzarides, T. Regulation of chromatin by histone modifications. Cell Res. 2011, 21, 381-395. [CrossRef] [PubMed]
135. Lauc, G, Vojta, A, Zoldos, V. Epigenetic regulation of glycosylation is the quantum mechanics of biology. Biochim. Biophys. Acta. 2014, 1840, 65-70. [CrossRef] [PubMed]
136. Morris, K.V, Mattick, J.S. The rise of regulatory rna. Nat. Rev. Genet. 2014, 15, 423-437. [CrossRef] [PubMed]
137. Wang, M, Wang, J, Kong, X, Chen, H, Wang, Y, Qin, M, Lin, Y, Chen, H, Xu, J, Hong, J, et al. Mir-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8. Sci. Rep. 2014, 4, 6145. [CrossRef] [PubMed]
138. Bernardi, C, Soffientini, U, Piacente, F, Tonetti, M.G. Effects of micrornas on fucosyltransferase 8 (FUT8) expression in hepatocarcinoma cells. PLoS ONE 2013, 8, e76540. [CrossRef] [PubMed]
139. Vaiana, C.A, Kurcon, T, Mahal, L.K. MicroRNA-424 predicts a role for beta-1,4 branched glycosylation in cell cycle progression. J. Biol. Chem. 2016, 291, 1529-1537. [CrossRef] [PubMed]
140. Kurcon, T, Liu, Z, Paradkar, A.V, Vaiana, C.A, Koppolu, S, Agrawal, P, Mahal, L.K. MiRNA proxy approach reveals hidden functions of glycosylation. Proc. Natl. Acad. Sci. USA 2015, 112, 7327-7332. [CrossRef] [PubMed]
141. Kasper, B.T, Koppolu, S, Mahal, L.K. Insights into mirna regulation of the human glycome. Biochem. Biophys. Res. Commun. 2014, 445, 774-779. [CrossRef] [PubMed]
142. Agrawal, P, Kurcon, T, Pilobello, K.T, Rakus, J.F, Koppolu, S, Liu, Z, Batista, B.S, Eng, W.S, Hsu, K.L, Liang, Y, et al. Mapping posttranscriptional regulation of the human glycome uncovers microrna defining the glycocode. Proc. Natl. Acad. Sci. USA 2014, 111, 4338-4343. [CrossRef] [PubMed]
143. Hart, G.W, Slawson, C, Ramirez-Correa, G, Lagerlof, O. Cross talk between O-glcnacylation and phosphorylation: Roles in signaling, transcription, and chronic disease. Annu. Rev. Biochem. 2011, 80, 825-858. [CrossRef] [PubMed]
144. Sasai, K, Ikeda, Y, Fujii, T, Tsuda, T, Taniguchi, N. UDP-glcnac concentration is an important factor in the biosynthesis of beta1,6-branched oligosaccharides: Regulation based on the kinetic properties of N-acetylglucosaminyltransferase v. Glycobiology 2002, 12, 119-127. [CrossRef] [PubMed]
145. Boroughs, L.K, DeBerardinis, R.J. Metabolic pathways promoting cancer cell survival and growth. Nat. Cell Biol. 2015, 17, 351-359. [CrossRef] [PubMed]
146. Nakajima, K, Kitazume, S, Angata, T, Fujinawa, R, Ohtsubo, K, Miyoshi, E, Taniguchi, N. Simultaneous determination of nucleotide sugars with ion-pair reversed-phase hplc. Glycobiology 2010, 20, 865-871. [CrossRef] [PubMed]
147. Nakajima, K, Ito, E, Ohtsubo, K, Shirato, K, Takamiya, R, Kitazume, S, Angata, T, Taniguchi, N. Mass isotopomer analysis of metabolically labeled nucleotide sugars and N- and O-glycans for tracing nucleotide sugar metabolisms. Mol. Cell. Proteomics 2013, 12, 2468-2480. [CrossRef] [PubMed]
148. Korekane, H, Park, J.Y, Matsumoto, A, Nakajima, K, Takamatsu, S, Ohtsubo, K, Miyamoto, Y, Hanashima, S, Kanekiyo, K, Kitazume, S, et al. Identification of ectonucleotide pyrophosphatase/phosphodiesterase 3 (ENPP3) as a regulator of N-acetylglucosaminyltransferase GnT-IX (GnT-Vb). J. Biol. Chem. 2013, 288, 27912-27926. [CrossRef] [PubMed]
149. Radhakrishnan, P, Dabelsteen, S, Madsen, F.B, Francavilla, C, Kopp, K.L, Steentoft, C, Vakhrushev, S.Y, Olsen, J.V, Hansen, L, Bennett, E.P, et al. Immature truncated O-glycophenotype of cancer directly induces oncogenic features. Proc. Natl. Acad. Sci. USA 2014, 111, E4066-E4075. [CrossRef] [PubMed]
150. Gill, D.J, Tham, K.M, Chia, J, Wang, S.C, Steentoft, C, Clausen, H, Bard-Chapeau, E.A, Bard, F.A. Initiation of galnac-type O-glycosylation in the endoplasmic reticulum promotes cancer cell invasiveness. Proc. Natl. Acad. Sci. USA 2013, 110, E3152-E3161. [CrossRef] [PubMed]
151. Sasai, K, Ikeda, Y, Ihara, H, Honke, K, Taniguchi, N. Caveolin-1 regulates the functional localization of N-acetylglucosaminyltransferase III within the golgi apparatus. J. Biol. Chem. 2003, 278, 25295-25301. [CrossRef] [PubMed]
152. Wang, Z, Wang, N, Liu, P, Peng, F, Tang, H, Chen, Q, Xu, R, Dai, Y, Lin, Y, Xie, X, et al. Caveolin-1, a stress-related oncotarget, in drug resistance. Oncotarget 2015, 6, 37135-37150. [PubMed]
153. Thaysen-Andersen, M, Packer, N.H. Site-specific glycoproteomics confirms that protein structure dictates formation of N-glycan type, core fucosylation and branching. Glycobiology 2012, 22, 1440-1452. [CrossRef] [PubMed]
154. Sethi, M.K, Kim, H, Park, C.K, Baker, M.S, Paik, Y.K, Packer, N.H, Hancock, W.S, Fanayan, S, Thaysen-Andersen, M. In-depth N-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation. Glycobiology 2015, 25, 1064-1078. [CrossRef] [PubMed]
155. Moh, E.S, Thaysen-Andersen, M, Packer, N.H. Relative versus absolute quantitation in disease glycomics. Proteomics Clin. Appl. 2015, 9, 368-382. [CrossRef] [PubMed]
156. Levery, S.B, Steentoft, C, Halim, A, Narimatsu, Y, Clausen, H, Vakhrushev, S.Y. Advances in mass spectrometry driven O-glycoproteomics. Biochim. Biophys. Acta 2015, 1850, 33-42. [CrossRef] [PubMed]
157. Laughlin, S.T, Bertozzi, C.R. Imaging the glycome. Proc. Natl. Acad. Sci. USA 2009, 106, 12-17. [CrossRef] [PubMed]
158. Zhang, X, Zhang, Y. Applications of azide-based bioorthogonal click chemistry in glycobiology. Molecules 2013, 18, 7145-7159. [CrossRef] [PubMed]
159. Rabuka, D, Hubbard, S.C, Laughlin, S.T, Argade, S.P, Bertozzi, C.R. A chemical reporter strategy to probe glycoprotein fucosylation. J. Am. Chem. Soc. 2006, 128, 12078-12079. [CrossRef] [PubMed]
160. Hanashima, S, Inamori, K, Manabe, S, Taniguchi, N, Ito, Y. Systematic synthesis of bisubstrate-type inhibitors of N-acetylglucosaminyltransferases. Chemistry 2006, 12, 3449-3462. [CrossRef] [PubMed]
161. Hanashima, S, Korekane, H, Taniguchi, N, Yamaguchi, Y. Synthesis of N-glycan units for assessment of substrate structural requirements of N-acetylglucosaminyltransferase III. Bioorg. Med. Chem. Lett. 2014, 24, 4533-4537. [CrossRef] [PubMed]
162. Ihara, H, Ikeda, Y, Toma, S, Wang, X, Suzuki, T, Gu, J, Miyoshi, E, Tsukihara, T, Honke, K, Matsumoto, A, et al. Crystal structure of mammalian alpha1,6-fucosyltransferase, FUT8. Glycobiology 2007, 17, 455-466. [CrossRef] [PubMed]